Research programme: anti-infectives - Telum
Alternative Names: TC-101Latest Information Update: 16 Jul 2016
At a glance
- Originator Telum Corporation
- Class Fatty acids; Fatty alcohols
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Mycoses; Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Mycoses in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in USA